]>
IRCT20200412047048N1 IRCT 2020-06-15 Tehran University of Medical Sciences Evaluation of the effect of oral monte locust in the treatment of acute asthma in children Assessing the Effect of Oral Monte Locasta Compared with Pharmacology in Asthma Attacks, In addition to the common treatment of asthma attacks as a two-course, an accident in children aged 1-14 years with asthma 2019-02-04 anticipated 100 Complete https://irct.ir/trial/47719 interventional Randomization: Not randomized, Blinding: Double blinded, Placebo: Used, Assignment: Other, Purpose: Treatment, Blinding description: Patients and their families were explained the study before prescribing the drug, and those who agreed to work were kept blind. The main researcher and the presenter were kept blind until the end of the study and the results were determined. The medical staff (nurses and other physician colleagues) were kept blind to the study. The project manager and statistical officer reviewed the data until the results were blind. 3 Asthma. Intervention 1: In the intervention group, which included children aged 1-14 years with a diagnosis of asthma attack, Monte Lukast 5 mg / 4.5 tablets for children under 1 year of age and one complete tablet for children over 5 years of age at the time of the attack and then up to 7 times daily. The day was used. The above medicine was prepared by Obaidi Pharmaceutical Company. Intervention 2: The control group included children aged 1-14 diagnosed with an asthma attack who were randomly selected and received placebo, which was both the same color and the same size as Monte Lukast. Complete tablets for children over 5 years of age were used during the attack and then daily for up to 7 days. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Masoomeh Sobhani
Unit 2, No. 9, Fifth Alley., Ali Hosseini St., Ferdows Shargh Blvd
Tehran Iran (Islamic Republic of) 1481957141 +98 21 4405 0743 masoomeh.sbh@gmail.com Tehran University of Medical Sciences scientific Masoomeh Sobhani
Unit 2, No. 9, Fifth Alley., Ali Hosseini St., Ferdows Shargh Blvd
Tehran Iran (Islamic Republic of) 1481957141 +98 21 4405 0743 masoomeh.sbh@gmail.com Tehran University of Medical Sciences Iran (Islamic Republic of) All patients aged 1-14 years who are confirmed based on history and examination for asthma attack 1 year 14 years Both Those with a history of taking corticosteroids or montelukast for the past ten days All patients who developed a diagnosis other than asthma, such as pneumonia or bronchiolitis J45 Asthma Treatment - Drugs Placebo In the intervention group, which included children aged 1-14 years with a diagnosis of asthma attack, Monte Lukast 5 mg / 4.5 tablets for children under 1 year of age and one complete tablet for children over 5 years of age at the time of the attack and then up to 7 times daily. The day was used. The above medicine was prepared by Obaidi Pharmaceutical Company. The control group included children aged 1-14 diagnosed with an asthma attack who were randomly selected and received placebo, which was both the same color and the same size as Monte Lukast. Complete tablets for children over 5 years of age were used during the attack and then daily for up to 7 days. Asthma. Timepoint: At the beginning of the patient's visit, 1,4,8,24,48 hours after the intervention and one week after discharge from the hospital. Method of measurement: Patient scoreboard. Tehran University of Medical Sciences Approved 2019-02-02 Ethics Committee of Tehran University of Medical Sciences Unit 2,No. 9,Fifth Alley,Ali Hosseini St.,Ferdows Shargh Blvd.,Sadeghieh, Tehran Tehran Iran (Islamic Republic of)